Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Malaria Treatment Market From 2025 to 2029?

In recent times, the malaria treatment market has witnessed consistent growth. Expected to rise from $1.55 billion in 2024 to $1.61 billion in 2025, it shows a compound annual growth rate (CAGR) of 3.9%. The discovery of potent drugs, efforts towards vector control, worldwide health campaigns, advancements in scientific research, and the construction of better health infrastructure have all significantly contributed to the growth observed in the historical period.

Predicted robust growth is anticipated in the malaria treatment market in the coming years, with it increasing to $2.03 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this growth during the forecast period are linked to drug resistance monitoring, the effects of climate change, precision medicine and genomic tactics, reforms in healthcare financing, as well as the incorporation of digital health solutions. Furthermore, throughout the forecast period, major trends are expected to be improvement in epidemiological surveillance, integration of alternative medicine, developing malaria vaccines, the implementation of data-driven treatment plans and enhancing education and training programs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11939&type=smp

What Elements Are Contributing To Growth In The Malaria Treatment Market?

The surge in malaria cases is set to drive expansion in the market for malaria treatment. Malaria, a potentially deadly disease transmitted through mosquito bites and caused by the Plasmodium parasite, is often accompanied by recurrent fever and symptoms similar to the flu. This increase can be attributed to impoverished conditions, inadequate healthcare, climate change, the absence of malaria containment strategies, and resistance to drugs. Malaria treatment aids in managing and eliminating the infection induced by the Plasmodium parasite. For example, the World malaria report 2023, published by the World Health Organization, an intergovernmental organization based in Switzerland, noted that global malaria cases in 2022 amounted to 249 million, a rise of five million from 2021. Consequently, the escalating incidence of malaria is fueling the expansion of the malaria treatment market.

Which Segments Are Detailed In The Global Malaria Treatment Market Report?

The malaria treatment market covered in this report is segmented –

1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments

2) By Route Of Administration: Oral, Parenteral, Intravenous

3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications

2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines

3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests

4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures

Which Emerging Trends And Strategic Shifts Are Shaping The Malaria Treatment Market?

Leading corporations involved in the malaria treatment market are focusing on the advancement of technologies such as the VERV Program. This initiative is designed to improve the efficacy and effectiveness of diagnosing and treating malaria, ultimately aimed at lessening the impact of the disease in regions where it is prevalent. The VERV Program, an initiative of the Environmental Protection Agency (EPA), promotes the creation of novel mosquito control products to tackle diseases like malaria by providing expedited review vouchers for registration. For example, in December 2023, the Vector Expedited Review Voucher (VERV) Program was initiated by the EPA, a government agency headquartered in the US. The VERV Program will offer monetary incentives to businesses that invent new pesticides to specifically target mosquito groups that are resistant to conventional pesticides. The program will enable a quicker registration process for eligible products, thereby speeding up their entry into the market.

Who Are The Key Contributors To Growth In The Malaria Treatment Market?

Major companies operating in the malaria treatment market include Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC., Takeda Pharmaceutical Company Limited, Sumitomo Chemical Co. Ltd., Viatris Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Zydus Lifesciences Ltd., Medicines Sans Frontières, Strides Pharma Science Limited, Swiss Tropical and Public Health Institute (Swiss TPH), AdvaCare Pharma USA LLC, Medicines for Malaria Venture (MMV), VLP Therapeutics LLC, Actiza Pharmaceutical Private Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Which Region Is Projected To Lead The Malaria Treatment Market By 2025?

Middle East and Africa was the largest region in the malaria treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11939&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model